ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $409,000 | -62.0% | 188,616 | -38.6% | 0.04% | -59.4% |
| Q2 2021 | $1,076,000 | -84.6% | 307,442 | -56.5% | 0.11% | -85.3% |
| Q1 2021 | $6,975,000 | -25.0% | 707,442 | -17.5% | 0.72% | -25.2% |
| Q4 2020 | $9,301,000 | +5.3% | 858,000 | 0.0% | 0.97% | +1.4% |
| Q3 2020 | $8,837,000 | -39.8% | 858,000 | +22.0% | 0.95% | -47.1% |
| Q2 2020 | $14,679,000 | +83.9% | 703,000 | -13.9% | 1.80% | +106.7% |
| Q1 2020 | $7,982,000 | +30.7% | 816,945 | +54.2% | 0.87% | +66.5% |
| Q4 2019 | $6,105,000 | +94.6% | 529,945 | -7.9% | 0.52% | +113.5% |
| Q3 2019 | $3,137,000 | -57.0% | 575,645 | -6.3% | 0.24% | -48.3% |
| Q2 2019 | $7,303,000 | +56.8% | 614,199 | -30.9% | 0.47% | +68.1% |
| Q1 2019 | $4,657,000 | +15.0% | 888,722 | -30.9% | 0.28% | +43.1% |
| Q4 2018 | $4,049,000 | -41.8% | 1,285,400 | +11.8% | 0.20% | -13.6% |
| Q3 2018 | $6,958,000 | – | 1,150,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |